Utilization of immunosuppressants by people with renal transplant

Objective: To analyze the use of immunosuppressants for people with renal transplant. Methods: A qualitativedescriptive approach was used, conducted with 20 people that underwent renal transplant, in the period from May to July 2013. The data collection was done through semi-structured interview and...

Full description

Saved in:
Bibliographic Details
Published in:Revista de pesquisa, cuidado é fundamental cuidado é fundamental, 2017-10, Vol.9 (4), p.1145-1153
Main Authors: dos Santos, Bianca Pozza, Farias, Juliana Soares, Farias, Luciana, Feijó, Aline Machado, Viegas, Aline da Costa, Schwartz, Eda
Format: Article
Language:English
Subjects:
Chronic renal insufficiency
Enfermagem
Enfermería
Health care
Immunosuppressive agents
Imunossupressores
Inmunosupresores
Insuficiencia renal crónica
Insuficiência renal crônica
Kidney diseases
Kidney transplantation
Kidneys
Medicações imunossupressoras no transplante renal
Nursing
Quality of life
Transplante De Rim
Transplants & implants
Trasplante de riñón
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To analyze the use of immunosuppressants for people with renal transplant. Methods: A qualitativedescriptive approach was used, conducted with 20 people that underwent renal transplant, in the period from May to July 2013. The data collection was done through semi-structured interview and used the thematic analysis. Results: Ten men and ten women participated, age between 30 and 66 years, mostly of the white race, catholic, married, with incomplete primary education and retired. Three categories were identified: routine use of immunosuppressants; presence of side effects of immunosuppressants; and dispensing of immunosuppressants. Conclusion: The study presents singularities of the dependents' experience of an ongoing drug treatment, therefore providing theoretical subsidies that may qualify the care practices aimed at people living in the dependence of these drugs.
ISSN:2175-5361
2175-5361
DOI:10.9789/2175-5361.2017.v9i4.1145-1153